US
Virtus Biotech Clinical Trials ETF
BBC · Equity
$44.54
-0.32%
Assets
n/a
Expense ratio
0.65%
Holdings
124
1Y return
+162.1%
Forward P/E
n/a
Top 10 holdings
+15.8%
Return and risk
| 1Y total return | +162.1% |
| 3Y total return | +85.3% |
| 5Y total return | -0.0% |
| 3Y CAGR | +22.8% |
| 5Y CAGR | -0.0% |
| Beta | 0.92 |
| RSI | 50.61 |
Fund structure
| Asset class | Equity |
| Assets | n/a |
| Holdings | 124 |
| Expense ratio | 0.65% |
| Dividend yield | +1.5% |
| Top 10 holdings | +15.8% |
| Volume | 15K |
All ETF indicators
| All Time High | 62.6 |
| All Time High Change | -28.85 |
| All Time High Date | 2021-02-10 |
| All Time Low | 13.42 |
| All Time Low Change | 231.9 |
| All Time Low Date | 2025-04-09 |
| Atr | 1.33 |
| Beta | 0.92 |
| Cagr10y | 10 |
| Cagr1y | 162.29 |
| Cagr3y | 22.82 |
| Cagr5y | -0 |
| Ch10y | 148.97 |
| Ch1m | 2.63 |
| Ch1w | -0.83 |
| Ch1y | 157.76 |
| Ch3m | 9.71 |
| Ch3y | 79.77 |
| Ch5y | -2.98 |
| Ch6m | 39.21 |
| Ch YTD | 15.51 |
| Close | 44.68 |
| Div CAGR3 | 99.7 |
| Div CAGR5 | 51.44 |
| Dividend Growth | 173.7 |
| Dividend Growth Years | 2 |
| Dividend Years | 3 |
| Dividend Yield | 1.47 |
| Dps | 0.66 |
| Ex Div Date | 2025-12-22 |
| High52 | 48.18 |
| High52ch | -7.55 |
| High52 Date | 2026-04-21 |
| Inception Date | 2014-12-16 |
| Isin | US26923G3011 |
| Last Dividend | 0.66 |
| Low52 | 16.85 |
| Low52ch | 164.34 |
| Low52 Date | 2025-05-15 |
| Ma150 | 39.07 |
| Ma150ch | 14.01 |
| Ma20 | 45.41 |
| Ma200 | 35.24 |
| Ma200ch | 26.39 |
| Ma20ch | -1.92 |
| Ma50 | 43.24 |
| Ma50ch | 3.02 |
| Payment Date | 2025-12-29 |
| Payout Frequency | Annual |
| Price Date | 2026-05-12 |
| Rsi | 50.61 |
| Rsi Monthly | 74.2 |
| Rsi Weekly | 63.55 |
| Sharpe Ratio | 2.79 |
| Sortino Ratio | 5.04 |
| Top10holdings | 15.83 |
| Tr10y | 159.43 |
| Tr1m | 2.63 |
| Tr1y | 162.12 |
| Tr3m | 9.71 |
| Tr3y | 85.29 |
| Tr5y | -0 |
| Tr6m | 41.56 |
| Tr YTD | 15.51 |